(Q51182085)
Statements
Six-month stability of bevacizumab (Avastin) binding to vascular endothelial growth factor after withdrawal into a syringe and refrigeration or freezing (English)
Sophie J Bakri
Melissa R Snyder
Jose S Pulido
William T Weiss
Ravinder J Singh